CORDIS · 316120 · FP7
GLOWBRAIN Combining Stem Cells and Biomaterials for Brain Repair - Unlocking the Potential of the Existing Brain Research through Innovative In Vivo Molecular Imaging
Coordinator: SVEUCILISTE U ZAGREBU MEDICINSKI FAKULTET (HR)
The main aim of GlowBrain is to unlock the existing research potential of University of Zagreb School of Medicine and respond to an emerging need for combined stem cells and biomaterials applications in brain repair. The already existing platform for mouse brain research is currently involved in research of molecular mechanisms underlying brain damage and repair. It includes the expertise and equipment to assess the brain at system (behavioral analysis, neuroanatomy and neurodevelopment), cellular (microscopy and in vitro techniques) and molecular levels (molecular biology techniques). Throug…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
Co-funding: the European Union contributes €3.8M toward a total project budget of €4.2M — a funding rate of 89%, with the remainder covered by the consortium partners. The project runs over approximately 3.5 years from 2012-10-01 to 2016-03-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from HR
see all →- MARBLE — Centre of Excellence in Maritime Robotics and Technologies for Sustainable Blue Economy101136349 · HORIZON · €15.0M
- ANEUPLOIDY — Molecular origins of aneuploidies in healthy and diseased human tissues855158 · H2020 · €10.0M
- InnoThyroGen — Innovating Thyroid Health with Genomics and Predictive Algorithms through Collaborative Excellence101187880 · HORIZON · €4.9M
- INNOMOL — Enhancement of the Innovation Potential in SEE through new Molecular Solutions in Research and Development316289 · FP7 · €4.7M
- ACROSS — Centre of Research Excellence for Advanced Cooperative Systems285939 · FP7 · €3.4M
- INTEGRA-LIFE — Integrating research in molecular life sciences at the University of Zagreb315997 · FP7 · €3.2M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CSA-SA funding scheme.
- What is the EU contribution?
- The European Commission contributes €3.8M toward a total project budget of €4.2M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by SVEUCILISTE U ZAGREBU MEDICINSKI FAKULTET (HR).
- What is the project timeline?
- The project runs from 2012-10-01 to 2016-03-31 — approximately 3.5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 316120.